To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene INTS4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
239 supporting clones for gene INTS4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB487140.
matches multiple genes
hypothalamus .a -11 to 434 1 to 446     also hits gene wakami 446/446
(100 %)
0 diff
(100 %id)
CF593758 Human Placenta, placenta .a 1 to 545 30 to 576       553/836
(66 %)
12 diff
(98.6 %id)
NM_033547.3   .a 1 to 3142 6 to 3147 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 3147/3147
(100 %)
0 diff
(100 %id)
AK290866   .a 1 to 2958 2 to 2959 S459A     2959/2959
(100 %)
4 diff
(99.9 %id)
BF313780 brain, neuroblastoma .a 1 to 764 2 to 764   tiling clone,   764/764
(100 %)
8 diff
(99.0 %id)
BP357824 mammary gland .a 1 to 580 2 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA648804   .a 1 to 566 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DB218931 trachea .a 1 to 517 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
BG470045 adenocarcinoma cell line, colon .a 3 to 681 1 to 695       693/768
(90 %)
33 diff
(95.8 %id)
BP250916 hippocampus .a 4 to 585 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP250939 hippocampus .a 4 to 585 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BG747609 eye, normal pigmented retinal epithelium .a 4 to 670 1 to 670       670/748
(89 %)
10 diff
(98.7 %id)
CD635199   .a 5 to 556 552 to 1       552/559
(98 %)
4 diff
(99.3 %id)
AL530149 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 8 to 851 1 to 842       842/842
(100 %)
11 diff
(98.7 %id)
AL552071 placenta, Placenta Cot 25-normalized .a 8 to 942 16 to 954       939/954
(98 %)
19 diff
(98.1 %id)
BX402388.
matches multiple genes
placenta, Placenta Cot 25-normalized .a 11 to 940 1 to 930   fully sequenced, also hits gene ANKRA2 930/930
(100 %)
0 diff
(100 %id)
BX402601 Placenta Cot 25-normalized .a 11 to 936 1 to 925       925/931
(99 %)
8 diff
(99.2 %id)
AL552358 placenta, Placenta Cot 25-normalized .a 11 to 918 1 to 906       906/906
(100 %)
6 diff
(99.4 %id)
BI086575 cervix .a 12 to 680 1 to 696       693/789
(87 %)
37 diff
(95.4 %id)
DR001512 fetal brain .a 14 to 590 8 to 584       577/584
(98 %)
6 diff
(99.0 %id)
CD635198   .a 15 to 557 1 to 544       544/545
(99 %)
4 diff
(99.3 %id)
AL526683 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 15 to 474 1 to 459       459/459
(100 %)
5 diff
(99.0 %id)
BG705669 brain, hypothalamus .a 15 to 662 1 to 653       653/653
(100 %)
8 diff
(98.8 %id)
BG714833 brain, hypothalamus .a 15 to 634 1 to 642       640/753
(84 %)
38 diff
(95.0 %id)
BI597813 brain, hypothalamus .a 15 to 763 1 to 750       750/750
(100 %)
13 diff
(98.3 %id)
BI766062 pooled lung and spleen .a 17 to 820 1 to 809       809/842
(96 %)
12 diff
(98.6 %id)
TI_57177981   .a 17 to 820 72 to 880       809/913
(88 %)
18 diff
(98.1 %id)
TI_1948135823   .a 18 to 682 121 to 790       670/1338
(50 %)
29 diff
(97.9 %id)
TI_1948136180   .a 18 to 819 116 to 921       806/1312
(61 %)
31 diff
(97.7 %id)
TI_1948136530   .a 18 to 897 113 to 986       874/1241
(70 %)
26 diff
(98.0 %id)
BE263222 brain, neuroblastoma .a 20 to 507 1 to 486       486/486
(100 %)
3 diff
(99.4 %id)
TI_45213744   .a 20 to 763 89 to 833       745/833
(89 %)
16 diff
(98.1 %id)
BE312445 brain, neuroblastoma .a 21 to 627 1 to 607       607/682
(89 %)
14 diff
(98.0 %id)
TI_1948135469   .a 21 to 820 130 to 934       805/1432
(56 %)
18 diff
(98.8 %id)
BM804406 lymph, lymphoma, cell line .a 22 to 918 1 to 910       771/1099
(70 %)
48 diff
(95.7 %id)
CN332774 embryonic stem cells, cell lines H1, H7, andH9 .a 23 to 792 1 to 770       770/770
(100 %)
3 diff
(99.7 %id)
CV028348 mixed .a 24 to 646 1 to 623       623/623
(100 %)
0 diff
(100 %id)
CD635200   .a 26 to 557 8 to 539       532/540
(98 %)
9 diff
(98.4 %id)
CD635201   .a 26 to 545 518 to 1       518/525
(98 %)
4 diff
(99.3 %id)
CD635202   .a 26 to 557 8 to 539       532/540
(98 %)
8 diff
(98.6 %id)
CD635203   .a 26 to 555 530 to 1       530/537
(98 %)
1 diff
(99.9 %id)
CN332777 embryonic stem cells, cell lines H1, H7, andH9 .a 29 to 764 1 to 736       736/736
(100 %)
0 diff
(100 %id)
BG259062 embryonal carcinoma, cell line, testis .a 49 to 680 1 to 649       649/1059
(61 %)
32 diff
(97.0 %id)
AL834171 melanoma (MeWo cell line) .a 53 to 3144 1 to 3093   available from DKFZ,   3093/3100
(99 %)
6 diff
(99.9 %id)
BQ216049 large cell carcinoma, lung .a 58 to 885 1 to 833       833/834
(99 %)
13 diff
(98.5 %id)
BI460221 testis .a 78 to 568 91 to 581       581/581
(100 %)
4 diff
(99.4 %id)
CN332776 embryonic stem cells, cell lines H1, H7, andH9 .a 82 to 796 1 to 715       715/715
(100 %)
0 diff
(100 %id)
CD635204   .a 86 to 557 8 to 479       472/480
(98 %)
8 diff
(98.4 %id)
CD635205   .a 86 to 557 472 to 1       472/479
(98 %)
2 diff
(99.6 %id)
BG488712 large cell carcinoma, lung .a 107 to 617 1 to 511       511/511
(100 %)
2 diff
(99.7 %id)
BG177974 adenocarcinoma, cell line, Prostate .a 113 to 722 1 to 614       614/1002
(61 %)
11 diff
(99.0 %id)
BP357635 mammary gland .a 174 to 754 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
AI002913 schizophrenic brain S-11 frontal lobe .a 183 to 408 1 to 226     Submitted on the opposite strand 226/226
(100 %)
0 diff
(100 %id)
CN332775 embryonic stem cells, cell lines H1, H7, andH9 .a 219 to 905 1 to 687       687/687
(100 %)
2 diff
(99.8 %id)
CN332778 embryonic stem cells, cell lines H1, H7, andH9 .a 291 to 824 1 to 533       533/533
(100 %)
1 diff
(99.9 %id)
BU170247 embryonal carcinoma, cell line, testis .a 296 to 1168 1 to 881       881/888
(99 %)
11 diff
(98.8 %id)
CV573692 cornea, eye .a 308 to 928 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BU160049 leiomyosarcoma, uterus .a 323 to 1014 1 to 692       692/939
(73 %)
14 diff
(98.6 %id)
CN332773 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 366 to 820 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BE799664 lung, small cell carcinoma .a 388 to 1071 24 to 713       692/1046
(66 %)
19 diff
(98.2 %id)
BU844612 ovary, teratocarcinoma, cell line .a 478 to 1339 1 to 864       864/864
(100 %)
5 diff
(99.5 %id)
BU932126 ovary, teratocarcinoma, cell line .a 478 to 1377 1 to 902       902/925
(97 %)
12 diff
(98.8 %id)
BG943924 blood .a 509 to 1067 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
BF306819 muscle, rhabdomyosarcoma .a 542 to 1256 1 to 711       711/898
(79 %)
28 diff
(96.9 %id)
BC008013 Muscle, rhabdomyosarcoma .a 543 to 3077 1 to 2535   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 2535/2535
(100 %)
0 diff
(100 %id)
BE019034 muscle, rhabdomyosarcoma .a 581 to 1100 1 to 520       520/520
(100 %)
2 diff
(99.7 %id)
TI_1948136183   .a 722 to 1556 945 to 107       839/1197
(70 %)
18 diff
(98.5 %id)
TI_1948136532   .a 722 to 1556 944 to 109       836/1320
(63 %)
21 diff
(98.5 %id)
TI_1948135471   .a 728 to 1556 937 to 107       829/1194
(69 %)
9 diff
(99.3 %id)
TI_1948136533   .a 731 to 1556 934 to 106       829/1193
(69 %)
10 diff
(99.2 %id)
TI_1948135825   .a 732 to 1556 937 to 109       829/1331
(62 %)
22 diff
(98.4 %id)
BX348371 Placenta Cot 25-normalized .a 775 to 1537 6 to 772       767/772
(99 %)
42 diff
(94.6 %id)
CD651951 Embryonic Stem cells .a 791 to 1548 1 to 753       753/803
(93 %)
19 diff
(97.7 %id)
AW853066 colon .a 800 to 1413 618 to 4       615/618
(99 %)
3 diff
(99.6 %id)
TI_1948136182   .a 819 to 1556 852 to 109       744/1385
(53 %)
24 diff
(98.3 %id)
DN999028 bone marrow .a 872 to 1588 7 to 723       717/723
(99 %)
8 diff
(98.9 %id)
BX281490 leiomyosarcoma, uterus .a 888 to 1352 1 to 466       466/466
(100 %)
1 diff
(99.8 %id)
BE613821 leiomyosarcoma, uterus .a 908 to 1626 1 to 712       712/740
(96 %)
11 diff
(98.6 %id)
TI_1948135826   .a 941 to 1556 722 to 105       618/1204
(51 %)
3 diff
(99.8 %id)
AW604651 colon .a 1007 to 1495 2 to 489       487/489
(99 %)
14 diff
(97.2 %id)
TI_1948135470   .a 1047 to 1556 616 to 103       514/1343
(38 %)
27 diff
(98.0 %id)
BE694734 breast .a 1099 to 1474 15 to 382       368/395
(93 %)
18 diff
(95.5 %id)
BE539920 cervix .a 1175 to 1872 1 to 706       708/726
(97 %)
29 diff
(96.1 %id)
CN390909 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1306 to 2054 1 to 750       750/750
(100 %)
2 diff
(99.8 %id)
BC009859 Ovary, adenocarcinoma .a 1337 to 3142 1 to 1806   available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1806/1806
(100 %)
0 diff
(100 %id)
BE746397 adenocarcinoma cell line, ovary .a 1356 to 2040 1 to 715   available from MGC,   713/732
(97 %)
46 diff
(93.8 %id)
AA360980.
matches multiple genes
  .a 1440 to 1665 1 to 227     also hits gene INTS4L1, INTS4L2 227/234
(97 %)
1 diff
(99.6 %id)
AX810697   .a 1457 to 3141 1 to 1688       1688/1688
(100 %)
5 diff
(99.8 %id)
CX752251 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1460 to 2213 1 to 749     Submitted on the opposite strand 749/758
(98 %)
10 diff
(98.7 %id)
BE819494 breast_normal .a 1480 to 1769 1 to 294       294/348
(84 %)
11 diff
(96.9 %id)
AA322631.
matches multiple genes
brain, cerebellum .a 1494 to 1648 1 to 155     also hits gene INTS4L1, INTS4L2 155/155
(100 %)
0 diff
(100 %id)
AA375937 lung .a 1572 to 2022 1 to 453       453/453
(100 %)
3 diff
(99.4 %id)
N39974.
matches multiple genes
melanocyte .a 1597 to 1943 1 to 351     also hits gene C12orf45 351/353
(99 %)
6 diff
(98.4 %id)
BI044523 ovary .a 1608 to 1733 1 to 125       125/128
(97 %)
3 diff
(97.7 %id)
BQ439329 embryonal carcinoma, cell line, testis .a 1614 to 2467 1 to 863       863/894
(96 %)
14 diff
(98.5 %id)
BC006369 Muscle, rhabdomyosarcoma .a 1627 to 3077 1 to 1451   available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1451/1451
(100 %)
0 diff
(100 %id)
BF310026 muscle, rhabdomyosarcoma .a 1636 to 2446 1 to 800   available from MGC,   800/839
(95 %)
50 diff
(94.1 %id)
AA085536   .a 1672 to 2074 1 to 403       403/404
(99 %)
3 diff
(99.3 %id)
BI255710 cervical carcinoma cell line, cervix .a 1673 to 2436 1 to 766       766/962
(79 %)
10 diff
(99.0 %id)
W05791 lung .a 1699 to 2326 1 to 632       630/632
(99 %)
11 diff
(98.3 %id)
BF238070 B-cells, primary B-cells from tonsils (cell line) .a 1742 to 2446 1 to 687       687/889
(77 %)
35 diff
(96.1 %id)
AA307647 colon .a 1751 to 2219 1 to 468       468/468
(100 %)
1 diff
(99.8 %id)
BP422156 small intestine .a 1800 to 2318 1 to 519     Submitted on the opposite strand 519/519
(100 %)
1 diff
(99.9 %id)
CB992310 placenta, pre-eclamptic placenta .a 1825 to 2598 25 to 801       777/801
(97 %)
10 diff
(98.8 %id)
C16676   .a 1844 to 2162 1 to 318       318/318
(100 %)
4 diff
(98.8 %id)
C17327   .a 1844 to 2083 1 to 240       240/240
(100 %)
1 diff
(99.6 %id)
C17892 placenta .a 1844 to 2194 1 to 351       351/351
(100 %)
0 diff
(100 %id)
BQ318603 colon .a 1875 to 2275 13 to 413       401/413
(97 %)
7 diff
(98.4 %id)
BX283187 lung, small cell carcinoma .a 1876 to 2080 238 to 34     Submitted on the opposite strand 205/239
(85 %)
1 diff
(99.6 %id)
BQ318604 colon .a 1877 to 2067 13 to 202       190/202
(94 %)
7 diff
(96.6 %id)
BQ325059 colon_ins .a 1919 to 2511 594 to 3       592/594
(99 %)
8 diff
(98.7 %id)
AA353746   .a 1938 to 2251 1 to 316       316/320
(98 %)
4 diff
(98.8 %id)
R73209 breast .a 1944 to 2383 1 to 446       446/450
(99 %)
11 diff
(97.6 %id)
BG199892   .a 1945 to 2736 8 to 800       793/801
(99 %)
15 diff
(98.2 %id)
BQ335095 marrow .a 2003 to 2376 389 to 17       373/389
(95 %)
12 diff
(97.0 %id)
R18096 whole brain .a 2060 to 2400 1 to 343     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 343/402
(85 %)
6 diff
(98.6 %id)
CU444288 epidermis .a 2069 to 2872 820 to 17     Submitted on the opposite strand 804/820
(98 %)
2 diff
(99.8 %id)
BE264546 lung, small cell carcinoma .a 2123 to 2736 1 to 615       615/773
(79 %)
10 diff
(98.8 %id)
BX402387.
matches multiple genes
placenta, Placenta Cot 25-normalized .a 2126 to 3043 979 to 61   fully sequenced, AAA also hits gene ANKRA2 919/959
(95 %)
3 diff
(99.7 %id)
BX402600 Placenta Cot 25-normalized .a 2127 to 3110 983 to 1       983/983
(100 %)
5 diff
(99.5 %id)
AA004781 liver and spleen .a 2169 to 2584 1 to 416       416/416
(100 %)
3 diff
(99.3 %id)
T91681 lung .a 2172 to 2573 1 to 405       405/408
(99 %)
10 diff
(97.6 %id)
BM754780 Ascites, stomach .a 2175 to 2678 1 to 504       504/504
(100 %)
0 diff
(100 %id)
CN390910 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2197 to 2945 1 to 749       749/749
(100 %)
4 diff
(99.5 %id)
BP431803   .a 2239 to 2542 306 to 1       306/335
(91 %)
3 diff
(99.2 %id)
BM824605 Ascites, stomach .a 2250 to 2809 1 to 560       560/560
(100 %)
0 diff
(100 %id)
AL526652 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2252 to 3084 834 to 1       834/834
(100 %)
2 diff
(99.8 %id)
AL530148 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 2252 to 3098 850 to 1       850/850
(100 %)
17 diff
(98.0 %id)
AL575673 placenta, Placenta Cot 25-normalized .a 2254 to 3115 866 to 1       866/866
(100 %)
14 diff
(98.4 %id)
AL575588 placenta, Placenta Cot 25-normalized .a 2256 to 2740 865 to 379       487/499
(97 %)
5 diff
(99.0 %id)
TI_149287332   .a 2308 to 3142 891 to 58   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 834/1117
(74 %)
9 diff
(99.2 %id)
H14900 breast .a 2333 to 2686 1 to 358       358/358
(100 %)
5 diff
(98.7 %id)
H39676 breast .a 2333 to 2544 1 to 213       213/213
(100 %)
1 diff
(99.6 %id)
AA102036 colon, tumor .a 2334 to 2707 1 to 385       385/464
(82 %)
19 diff
(96.0 %id)
AA444096 ovarian tumor, ovary .a 2352 to 2557 1 to 206       206/206
(100 %)
1 diff
(99.6 %id)
CA312726 Human Lung Epithelial cells, lung .a 2380 to 3144 781 to 17       765/781
(97 %)
2 diff
(99.8 %id)
T93857 liver and spleen .a 2403 to 2559 1 to 158       158/160
(98 %)
5 diff
(96.9 %id)
R07402 liver and spleen .a 2404 to 2712 1 to 323       323/324
(99 %)
18 diff
(94.5 %id)
BM972671 lung .a 2411 to 3142 750 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 732/732
(100 %)
0 diff
(100 %id)
BU619596 Cell Line, Chondrosarcoma .a 2412 to 3144 749 to 17       733/749
(97 %)
1 diff
(99.9 %id)
CA427438 Cell Line, Chondrosarcoma .a 2450 to 3142 711 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 693/693
(100 %)
0 diff
(100 %id)
BE858835 brain, glioblastoma (pooled) .a 2469 to 3143 674 to 1       674/690
(97 %)
10 diff
(98.6 %id)
BM013230 brain, neuroblastoma, cell line .a 2503 to 3142 698 to 34   AAA Submitted on the opposite strand 665/1038
(64 %)
57 diff
(94.6 %id)
TI_59380104   .a 2503 to 3142 789 to 125   AAA Submitted on the opposite strand 665/1038
(64 %)
57 diff
(94.6 %id)
AA248773   .a 2512 to 2816 1 to 305       305/305
(100 %)
1 diff
(99.7 %id)
BQ025452 placenta .a 2513 to 3144 648 to 17       632/648
(97 %)
0 diff
(100 %id)
BF439977 brain, glioblastoma (pooled) .a 2517 to 3143 627 to 1       627/627
(100 %)
15 diff
(97.7 %id)
CA425259 Bone, Subchondral Bone .a 2541 to 3144 620 to 17       604/620
(97 %)
0 diff
(100 %id)
N21021 melanocyte .a 2563 to 3142 586 to 1       588/591
(99 %)
14 diff
(97.7 %id)
BQ025073 placenta .a 2563 to 3142 598 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 580/580
(100 %)
3 diff
(99.5 %id)
AV727291 hypothalamus .a 2571 to 3075 505 to 1     Submitted on the opposite strand 505/505
(100 %)
1 diff
(99.9 %id)
AW467450 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 2577 to 3077 501 to 1       501/501
(100 %)
0 diff
(100 %id)
BE677840 pooled .a 2577 to 3100 524 to 1       524/524
(100 %)
2 diff
(99.7 %id)
AA781113   .a 2579 to 3100 522 to 1       522/522
(100 %)
2 diff
(99.7 %id)
BP397737 pancreatic islet .a 2586 to 3142 1 to 558     Submitted on the opposite strand 558/558
(100 %)
1 diff
(99.9 %id)
AA082086   .a 2597 to 2935 1 to 341       341/341
(100 %)
2 diff
(99.5 %id)
AA629845 lung, lung carcinoma .a 2614 to 3080 468 to 1       468/471
(99 %)
2 diff
(99.6 %id)
BQ020832 lung, Metastatic Chondrosarcoma .a 2614 to 3142 547 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 529/553
(95 %)
0 diff
(100 %id)
AA098840   .a 2629 to 3115 488 to 1       488/489
(99 %)
6 diff
(98.8 %id)
BM705496 eye, RPE and Choroid .a 2632 to 2947 1 to 316   fully sequenced,   316/316
(100 %)
0 diff
(100 %id)
BE390457 endometrium, adenocarcinoma cell line, uterus .a 2633 to 3140 1 to 510       510/685
(74 %)
5 diff
(99.3 %id)
BE727962 melanotic melanoma, skin .a 2633 to 3139 1 to 506   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 506/506
(100 %)
1 diff
(99.9 %id)
BE277503 melanotic melanoma, skin .a 2634 to 3140 1 to 507       507/639
(79 %)
4 diff
(99.4 %id)
BE387740 endometrium, adenocarcinoma cell line, uterus .a 2634 to 3144 1 to 510       510/751
(67 %)
3 diff
(99.7 %id)
BE388405 endometrium, adenocarcinoma cell line, uterus .a 2634 to 3144 1 to 510       510/671
(76 %)
4 diff
(99.5 %id)
BP394730 pancreatic islet .a 2653 to 3144 1 to 492   tiling clone, Submitted on the opposite strand 492/497
(98 %)
1 diff
(99.8 %id)
AA043028 uterus .a 2662 to 3141 1 to 485   fully sequenced,   485/485
(100 %)
7 diff
(98.6 %id)
AI034382 liver and spleen .a 2673 to 3134 462 to 1       462/462
(100 %)
2 diff
(99.6 %id)
AI819985 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2673 to 3133 470 to 10       461/470
(98 %)
0 diff
(100 %id)
AI921466 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2673 to 3077 417 to 13   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 405/405
(100 %)
0 diff
(100 %id)
N75055 lung .a 2679 to 3139 476 to 1       476/476
(100 %)
10 diff
(97.9 %id)
AI057311 liver and spleen .a 2682 to 3142 458 to 1       458/458
(100 %)
1 diff
(99.8 %id)
AA677104 liver and spleen .a 2683 to 3134 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
AA879127 carcinoid, lung .a 2687 to 3100 414 to 1       414/414
(100 %)
2 diff
(99.6 %id)
AI523929 B-cell, chronic lymphotic leukemia .a 2691 to 3143 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AA146993 uterus .a 2692 to 3142 453 to 1       453/453
(100 %)
5 diff
(98.9 %id)
BU158430 embryonal carcinoma, cell line, testis .a 2695 to 3142 1 to 448   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 448/448
(100 %)
1 diff
(99.8 %id)
AI096821 uterus .a 2697 to 3142 446 to 1       446/446
(100 %)
0 diff
(100 %id)
R11508 liver and spleen .a 2698 to 3138 451 to 3       449/451
(99 %)
3 diff
(99.4 %id)
AW572863 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 2707 to 3077 371 to 1       371/371
(100 %)
2 diff
(99.5 %id)
AI033059 liver and spleen .a 2712 to 3142 431 to 1       431/431
(100 %)
2 diff
(99.6 %id)
T93806 liver and spleen .a 2728 to 3133 410 to 1       410/420
(97 %)
11 diff
(97.4 %id)
AA708631 uterus .a 2732 to 3142 411 to 1       411/411
(100 %)
0 diff
(100 %id)
BG183909   .a 2734 to 3077 1 to 344   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 344/344
(100 %)
12 diff
(96.6 %id)
T79644 liver and spleen .a 2735 to 3144 423 to 2       422/465
(90 %)
0 diff
(100 %id)
H14605 breast .a 2737 to 3134 402 to 1       402/413
(97 %)
10 diff
(97.6 %id)
BI253415 cervical carcinoma cell line, cervix .a 2745 to 3129 1 to 391       391/438
(89 %)
10 diff
(97.8 %id)
BE207815 muscle, rhabdomyosarcoma .a 2752 to 3097 347 to 2       346/347
(99 %)
0 diff
(100 %id)
AA443913 ovarian tumor, ovary .a 2755 to 3139 405 to 21   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
AA554166 breast .a 2756 to 3141 386 to 1       386/386
(100 %)
0 diff
(100 %id)
AA627628 colon, colon tumor RER+ .a 2764 to 2996 233 to 1       233/233
(100 %)
2 diff
(99.2 %id)
AA102037 colon, tumor .a 2792 to 3077 285 to 1       285/285
(100 %)
1 diff
(99.7 %id)
AA042807 uterus .a 2815 to 3142 330 to 1   fully sequenced,   330/330
(100 %)
1 diff
(99.7 %id)
FN125528 breast carcinoma .a 2820 to 2922 1 to 105       105/108
(97 %)
3 diff
(97.3 %id)
AI249094 liver and spleen .a 2820 to 3140 321 to 1       321/321
(100 %)
2 diff
(99.4 %id)
R73144 breast .a 2825 to 3122 302 to 1       302/303
(99 %)
10 diff
(96.7 %id)
AI085423 liver and spleen .a 2831 to 3134 304 to 1       304/304
(100 %)
2 diff
(99.4 %id)
Z40216 brain, total brain .a 2832 to 3142 311 to 1       311/311
(100 %)
1 diff
(99.7 %id)
AI032969 liver and spleen .a 2832 to 3134 302 to 1       302/302
(100 %)
2 diff
(99.4 %id)
AW190192 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2850 to 3142 306 to 13   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 294/294
(100 %)
1 diff
(99.7 %id)
AA765511 germinal center B cell .a 2851 to 3142 304 to 13   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 292/292
(100 %)
0 diff
(100 %id)
BG271683 normal head/neck tissue .a 2866 to 3144 282 to 4       279/282
(98 %)
0 diff
(100 %id)
AW189748 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2867 to 3142 276 to 1       276/276
(100 %)
3 diff
(99.0 %id)
AA864509 pooled germ cell tumors .a 2905 to 3142 238 to 1       238/238
(100 %)
2 diff
(99.2 %id)
BU730634 eye, RPE and Choroid .a 2917 to 3148 244 to 13   fully sequenced,   232/244
(95 %)
5 diff
(98.0 %id)
AA777383 liver and spleen .a 2987 to 3134 148 to 1       148/148
(100 %)
1 diff
(99.4 %id)
T93283 lung .a 2996 to 3083 88 to 1       88/88
(100 %)
0 diff
(100 %id)
R42990 whole brain .a 2997 to 3142 158 to 13   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 146/146
(100 %)
0 diff
(100 %id)
AA908729 carcinoid, lung .a 3058 to 3142 85 to 1       85/85
(100 %)
0 diff
(100 %id)
BG338663 leiomyosarcoma cell line, uterus .b 1 to 778 8 to 803       803/1107
(72 %)
54 diff
(95.2 %id)
BC015664 Uterus, leiomyosarcoma .b 1 to 3452 6 to 3457 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 3457/3457
(100 %)
0 diff
(100 %id)
EL735985 mixed .b 361 to 944 1 to 584       584/584
(100 %)
0 diff
(100 %id)
TI_1948225709   .b 361 to 1198 126 to 971   fully sequenced,   846/971
(87 %)
23 diff
(97.7 %id)
TI_1948225853   .b 361 to 1231 120 to 992   fully sequenced,   873/992
(88 %)
10 diff
(99.0 %id)
TI_1948226002   .b 361 to 1153 131 to 936   fully sequenced,   806/936
(86 %)
20 diff
(97.9 %id)
TI_1948226152   .b 361 to 1164 126 to 933   fully sequenced,   808/933
(86 %)
14 diff
(98.5 %id)
TI_1948226003   .b 1123 to 1892 894 to 112   fully sequenced,   783/894
(87 %)
12 diff
(98.7 %id)
TI_1948226153   .b 1134 to 1892 881 to 125   fully sequenced,   757/881
(85 %)
8 diff
(99.1 %id)
TI_1948225710   .b 1168 to 1892 862 to 123   fully sequenced,   740/862
(85 %)
15 diff
(98.3 %id)
TI_1948225854   .b 1201 to 1892 823 to 124   fully sequenced,   700/823
(85 %)
1 diff
(99.9 %id)
BY798734 eye .b 1430 to 2019 1 to 590       590/590
(100 %)
0 diff
(100 %id)
AF172822 aorta .b 1920 to 3447 1 to 1528   AAA   1528/1533
(99 %)
7 diff
(99.6 %id)
BC009995 Brain, neuroblastoma .c 1 to 1845 1 to 1845 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 1845/1845
(100 %)
0 diff
(100 %id)
AW363142 colon .c 1008 to 1584 1 to 585       592/585
(101 %)
24 diff
(95.9 %id)
BI038288 nervous_tumor .c 1524 to 1778 284 to 30       255/284
(89 %)
0 diff
(100 %id)
AA167762   .d 1 to 206 1 to 206   tiling clone, to resequence,   206/206
(100 %)
11 diff
(94.7 %id)
CN280426 embryonic stem cells, DMSO-treated H9 cellline .d 48 to 388 1 to 341   tiling clone,   341/341
(100 %)
3 diff
(99.2 %id)
CN280427 embryonic stem cells, cell lines H1, H7, andH9 .d 143 to 639 1 to 498   tiling clone,   498/498
(100 %)
5 diff
(99.0 %id)
AA167642   .d 1614 to 2250 621 to 1   tiling clone, to resequence,   621/676
(91 %)
15 diff
(97.8 %id)
AA324904 brain, cerebellum .e 1 to 779 1 to 428 K30X D100N S101R S103W H104K ... tiling clone, Suspected internal deletion 428/428
(100 %)
14 diff
(96.8 %id)
BY795979 eye .f 1 to 694 4 to 697   tiling clone,   697/697
(100 %)
0 diff
(100 %id)
TI_1948135468   .f 18 to 732 120 to 834       715/1318
(54 %)
17 diff
(98.8 %id)
TI_1948135824   .f 21 to 735 128 to 838   tiling clone,   711/1440
(49 %)
11 diff
(99.3 %id)
TI_1948136181   .f 21 to 754 128 to 859 H230P Q236* tiling clone,   732/1458
(50 %)
22 diff
(98.5 %id)
TI_1948136531   .f 21 to 742 128 to 851   tiling clone,   724/1463
(49 %)
16 diff
(99.0 %id)
CN390911 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 1 to 573 1 to 573   tiling clone,   573/573
(100 %)
1 diff
(99.9 %id)
AW390492 stomach .g 478 to 1110 648 to 21   tiling clone,   628/648
(96 %)
5 diff
(99.3 %id)
BG953977.
matches multiple genes
colon .h 1 to 222 231 to 12   tiling clone, also hits gene INTS4L1, INTS4L2, narcharbu 220/273
(80 %)
0 diff
(100 %id)
AW361819 colon .h 168 to 795 8 to 636   tiling clone,   629/636
(98 %)
10 diff
(98.5 %id)
BQ318600 colon .i 1 to 426 432 to 7 H29R D42G S50G T54A D83E ... tiling clone,   426/439
(97 %)
0 diff
(100 %id)
CB993212 placenta, pre-eclamptic placenta .j 1 to 557 29 to 586 T31A L43P R91K tiling clone,   564/862
(65 %)
18 diff
(98.0 %id)
CF597466 ovary .k 1 to 740 8 to 754 exact tiling clone,   754/756
(99 %)
24 diff
(96.9 %id)
BF695487 brain, primitive neuroectoderm .k 3 to 732 1 to 720 exact tiling clone,   720/913
(78 %)
31 diff
(96.7 %id)
BC018672 Brain, primitive neuroectodermal .k 14 to 952 4 to 940 I23M A24L T25L K26R K27N ... tiling clone, available from MGC, AAA   937/937
(100 %)
8 diff
(99.2 %id)
BF668962 brain, primitive neuroectoderm .k 14 to 738 1 to 722 I23M A24L T25L K26R K27N ... available from MGC,   722/741
(97 %)
30 diff
(96.0 %id)
AI627304 Kidney .k 457 to 950 494 to 1   tiling clone,   494/494
(100 %)
1 diff
(99.8 %id)
AA831541 germinal center B cell .k 561 to 956 413 to 18   AAA   396/396
(100 %)
1 diff
(99.8 %id)
AK000455   .l 1 to 1663 1 to 1663 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 1663/1664
(99 %)
1 diff
(100.0 %id)
BF677675 Prostate .l 479 to 1090 1 to 608       608/826
(73 %)
17 diff
(98.0 %id)
AA570073 colon .l 668 to 1103 437 to 2       436/437
(99 %)
0 diff
(100 %id)
BF089033 head_neck .m-u 1 to 488 1 to 487   tiling clone,   487/487
(100 %)
6 diff
(98.8 %id)
AW377153 colon .m-u 25 to 688 666 to 3 exact tiling clone,   664/666
(99 %)
0 diff
(100 %id)
AW377154 colon .m-u 98 to 688 598 to 8 exact tiling clone,   591/598
(98 %)
0 diff
(100 %id)
AA693826 liver and spleen .n-u 1 to 442 436 to 1 Y8I L9F F11Q R12S G13M ... tiling clone,   436/436
(100 %)
8 diff
(98.2 %id)
AA360980.
matches multiple genes
  L1.a 807 to 1032 1 to 227     also hits gene INTS4L1, INTS4L2 227/234
(97 %)
1 diff
(99.6 %id)
AA322631.
matches multiple genes
brain, cerebellum L1.a 861 to 1015 1 to 155     also hits gene INTS4L1, INTS4L2 155/155
(100 %)
0 diff
(100 %id)
BG953977.
matches multiple genes
colon L1.d-u 1 to 222 231 to 12 S44Q G45C R46Q W48V E49G ... tiling clone, also hits gene INTS4L1, INTS4L2, narcharbu 220/273
(80 %)
0 diff
(100 %id)
AA360980.
matches multiple genes
  L2.a 806 to 1031 1 to 227     also hits gene INTS4L1, INTS4L2 227/234
(97 %)
1 diff
(99.6 %id)
AA322631.
matches multiple genes
brain, cerebellum L2.a 860 to 1014 1 to 155     also hits gene INTS4L1, INTS4L2 155/155
(100 %)
0 diff
(100 %id)
BG953977.
matches multiple genes
colon L2.d-u 1 to 222 231 to 12 S44Q G45C R46Q W48V E49G ... tiling clone, also hits gene INTS4L1, INTS4L2, narcharbu 220/273
(80 %)
0 diff
(100 %id)
BP192980 brain Gene INTS4, variant not shown         Suspected internal deletion, this clone was ignored    
AW895122 nervous_normal Gene INTS4, variant not shown         This clone was ignored    
AI340103   Gene INTS4, variant not shown         Suspected internal deletion, this clone was ignored    
BE866483 bladder, carcinoma, cell line Gene INTS4, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI